SAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INC

SAREPTA THERAPEUTICS INC

No trades
See on Supercharts

Price target

21.540.000.00%
The 24 analysts offering 1 year price forecasts for 1SRPT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 28 analysts giving stock ratings to 1SRPT in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


1SRPT EPS for the last quarter is −4.25 EUR despite the estimation of −2.96 EUR. In the next quarter EPS is expected to reach 0.67 EUR. Track more of SAREPTA THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter SAREPTA THERAPEUTICS INC revenue is expected to reach ‪450.33 M‬ EUR. Check out SAREPTA THERAPEUTICS INC revenue and earnings and make informed decisions.
We've gathered opinions of 28 analysts rating 1SRPT stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.